Cita APA (7a ed.)
Abahssain, H., Souadka, A., Alem, R., Santoni, M., Battelli, N., Amela, E., . . . Errihani, H. (2024). Shifting Paradigms in TNBC Treatment: Emerging Alternatives to Capecitabine in the Post-Neoadjuvant Setting. Current Oncology, 31(7), 3771-3783.
Cita Chicago Style (17a ed.)
Abahssain, Halima, Amine Souadka, Rania Alem, Matteo Santoni, Nicola Battelli, Eric Amela, Antoine Lemaire, Joseph Rodriguez, y Hassan Errihani. "Shifting Paradigms in TNBC Treatment: Emerging Alternatives to Capecitabine in the Post-Neoadjuvant Setting." Current Oncology 31, no. 7 (2024): 3771-3783.
Cita MLA (9a ed.)
Abahssain, Halima, et al. "Shifting Paradigms in TNBC Treatment: Emerging Alternatives to Capecitabine in the Post-Neoadjuvant Setting." Current Oncology, vol. 31, no. 7, 2024, pp. 3771-3783.
Precaución: Estas citas no son 100% exactas.